Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer

Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer

Source: 
Forbes
snippet: 

Based on results of a study published earlier this week in The BMJ, angiotensin-converting-enzyme (ACE) inhibitors were associated with an increased risk of lung cancer, compared with a similar, but distinct type of blood pressure medication known as angiotensin-receptor blockers (ARBs).